4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001181431-07-058563
$ACADCIK 0001070494operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 6:26 PM ET
Size
10.4 KB
Accession
0001181431-07-058563
Insider Transaction Report
Form 4
Lundstrom Brian
Sr. VP, Bus. Devt.
Transactions
- Sale
Common Stock
2007-09-20$16.08/sh−1,318$21,193→ 100 total - Sale
Common Stock
2007-09-20$16.09/sh−100$1,609→ 0 total - Exercise/Conversion
Common Stock
2007-09-20$6.61/sh+1,418$9,373→ 1,418 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-09-20−1,418→ 77,500 totalExercise: $6.61Exp: 2014-11-23→ Common Stock (1,418 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were made pursuant to an automatic sales plan under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The plan provides for the non-discretionary periodic sales of stock (and corresponding exercises of options, if needed) pursuant to predetermined trading parameters that do not permit Mr. Lundstrom to exercise any influence over how, when or whether to effect trades under the plan after its adoption.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on November 24, 2005. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 6:26 PM ET
- Size
- 10.4 KB